简要报告:在接受cART治疗的艾滋病毒感染患者中,免疫失败与高髓状细胞衍生的抑制细胞频率有关

Germana Grassi1, Stefania Notari1, Stefania Cicalini2

  • 1Cellular Immunology and Pharmacology Laboratory, National Institute for Infectious Diseases "Lazzaro Spallanzani", Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.

概括

艾滋病毒+患者中高水平的髓质衍生抑制细胞 (MDSC) 与CD4+T细胞恢复不良相关,尽管抗逆转录病毒治疗,这表明MDSC是治疗点.